Greenberg Traurig’s David J. Dykeman Speaks at ACI Summit on Life Sciences IP Due Diligence

Nov 28, 2022

Posted by Greenberg Traurig, LLP

David J. Dykeman, co-chair of global law firm Greenberg Traurig, LLP’s global Life Sciences & Medical Technology Practice and co-managing shareholder of the firm’s Boston office, spoke on a panel titled “Ownership and Inventorship 2.0: Common and Contemporary IP Due Diligence Landmines for the Life Sciences,” Nov. 15 at the American Conference Institute (ACI) 5th Annual Summit on Life Sciences Intellectual Property (IP) Due Diligence. 

The panel discussed the implications for life sciences companies employing artificial intelligence (AI) technologies, unique due diligence strategies for life sciences IP assets involving AI, how to determine inventorship and ownership with multiple inventors, assessing the risk of litigation, analyzing the target company’s policies, and who owns data.

A registered patent attorney with 25 years of experience in patent and IP law, Dykeman focuses his practice on securing worldwide IP protection and related business strategy for high tech clients, with particular experience in life sciences, medical devices, robotics, materials, and information technology. Dykeman provides strategic patent portfolio development and IP advice for clients, including major research institutions, multinational corporations, and early-stage companies. He also performs patent due diligence to assess patent portfolios for venture capital investment, mergers and acquisitions, and licensing opportunities. An author of over 55 articles and a speaker at over 50 conferences on IP law, Dykeman is the founding co-chair of the American Bar Association’s Medical Devices Committee. In 2022, Dykeman was named “Patent Strategy Attorney of the Year for Massachusetts” by LMG Life Sciences.


About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.


About Greenberg Traurig’s Boston Office: Established in 1999, Greenberg Traurig’s Boston office is home to more than 80 attorneys practicing in the areas of bankruptcy and restructuring, corporate, emerging technology, energy, environmental, financial services, gaming, governmental affairs, intellectual property, labor and employment, life sciences and medical technology, litigation, public finance, real estate, and tax. An important contributor to the firm’s international platform, the Boston office includes a team of nationally recognized attorneys with both public and private sector experience. The team offers clients the value of decades of helping clients in complex legal matters and hands-on knowledge of the local business community, supported by the firm’s vast network of global resources.

About Greenberg Traurig: Greenberg Traurig, LLP has more than 2500 attorneys in 43 locations in the United States, Europe, Latin America, Asia, and the Middle East. The firm reported gross revenue of over $2 Billion for FY 2021 and is consistently among the top firms on the Am Law 100, Am Law Global 100, and NLJ 250. On the debut 2022 Law360 Pulse Leaderboard, it is a Top 15 firm. Greenberg Traurig is Mansfield Rule 5.0 Certified Plus by The Diversity Lab and the Center for Resource Solutions Green-e® Energy program certifies that the firm’s U.S. offices are 100% powered by renewable energy. The firm is often recognized for its focus on philanthropic giving, innovation, diversity, and pro bono. Web:



See all Member News